On March 15, the FDA reported that it had made determinations on more than 99 per cent of the nearly 26 million deemed products for which ...
The February 2023 GMDP symposia marked the first time since the world was impacted by the Covid 19 pandemic that the event could be held ...
The week of the 7th of March is among the most important for the cannabis industry in Spain and Europe. This week, Spannabis takes place: ...
Ben Green, a Broughton Program Manager working on large nicotine-related regulatory projects, writes on the latest move by FDA to enforce ...
The recent investigations by The Daily Mailconcerning the non-compliance of vape products on sale in UK retailers have highlighted the ...
The UN International Day of Women and Girls in Science on February 11th is an annual day celebrated across the global scientific community. ...
Broughton CEO, Chris Allen, looks at the emerging field of psychedelic pharmaceutical drug development and shares some of the best articles ...
Principal Scientist, Paul Barr, shares his takeaways from the recent Future Cannabis Strategies conference in London.
Broughton’s Business Development Manager for Animal Health, Luke Williams, looks at some of the key challenges facing animal health ...
Broughton’s Group Marketing Director takes a look at the FDA’s recent announcement that it is developing a regulatory assessment for CBD ...
Key issues affecting the cannabis industry in 2023
Trends in the Next Generation Nicotine Product Industry: 2022
How has the cannabis industry developed in 2022
What does 2023 have in store for the next-generation nicotine sector?
Day 1 of DDL opened with Federico Lavorini’s history and future of drug delivery, and it was a lively presentation… the perfect inhaler was ...
The 3rd Annual Extractables and Leachables (E&L) Conference
The Cochrane Library is a vast collection of databases which contain a variety of different types of high-quality, independent medical ...
Smoking is one of the most efficient and effective methods of delivering a drug to the lungs; which is one of the reasons smoking provides ...
In yet another twist on what is quickly becoming the PMTA saga, FDA last night ruled that the menthol variant of Logic was not appropriate ...
On November 9th at the ENDS US 2022 Conference, scientific and regulatory consultancy Broughton will be presenting on the regulatory ...
Pete Lomas, Managing Consultant for Product Realization, attended the Redefining Early Stage Investments conference to meet like-minded ...
The Broughton team were at the prestigious Four Seasons hotel in Georgetown, Washington DC for this year’s Global Tobacco and Nicotine ...
A new paper, Strategic insights to reignite PMTA confidence: Reduce costs and protect timelines whilst continuing to innovate, has been ...
Will an increase in youth vaping derail the UK’s commitment to a smoke-free future? The last couple of months has seen the release of two ...
Broughton Senior Consultant for Chemistry, Malcolm Saxton reflects on the 75th Tobacco Science Research Conference (TSRC) and the progress ...
E-cigarettes have the potential to achieve tobacco harm reduction as part of a controlled off-ramping journey – but there are roadblocks ...
Broughton Principal Scientist, Paul Barr, has written a white paper outlining the current legislation and regulatory landscape within the ...
Broughton's Regulatory Operations Manager, Emily Saunders, explains what cold-pressed CBD products are and why they are currently exempt ...
Broughton’s Chief Executive Officer, Chris Allen speaks to leading industry publication Cannabis Wealth about the company’s plans to ...
Broughton's Regulatory Operations Manager, Emily Saunders discusses the legalization of recreational cannabis in Germany and what this ...
Broughton's Regulatory Operations Manager, Emily Saunders discusses the key themes from Cannabis Europa 2022.
Modern Oral Nicotine Products (MONPs) are another exciting product innovation that can support the cause of worldwide tobacco harm ...
Broughton's Regulatory Operations Manager, Emily Saunders discusses why lengthy delays in the CBD approval process are causing frustration ...
Broughton's Chief Executive Officer, Chris Allen summarizes the highlights from Global Forum on Nicotine (GFN).
Broughton's Chief Commercial Officer, Andy Mooney summarizes the highlights from Next Generation Nicotine Delivery Conference USA.
Broughton celebrates Premarket Tobacco Product Application (PMTA) success for clients.
Broughton's Toxicology Managing Consultant Dr. Tony Jones summarizes the highlights and key takeaway messages from the Respiratory Drug ...
Broughton's Chief Scientific and Regulatory Officer Dr. Nveed Chaudhary discusses the recent FDA announcement on marketing orders and what ...
Broughton's Chief Scientific and Regulatory Officer Dr. Nveed Chaudhary discusses how England is leading the way internationally in terms ...
Broughton's Toxicology Consultant, Dr. Tony Jones shares his conference highlights from Extractables and Leachables, USA.
Broughton's Chief Scientific and Regulatory Officer Dr. Nveed Chaudhary talks to leading sector publication Tobacco Asia about ...
Broughton's Chief Scientific and Regulatory Officer Dr. Nveed Chaudhary discusses how cannabis has huge potential as a painkiller for ...
Broughton's Chief Scientific and Regulatory Officer, Dr Nveed Chaudhary has published an article on the recent FDA announcement on ...
Broughton's Chief Commercial Officer, Andy Mooney, discusses the latest synthetic nicotine legislation and what this means for ENDS ...
Broughton's Head of Regulatory Affairs, Lloyd Smart, and Technical Sales Administrator, Curtis Gallagher share thoughts on emerging topics ...
Broughton's Head of Regulatory Affairs, Lloyd Smart, has recently published an article with the leading sector publication, PharmTech.
Broughton is establishing a U.S. subsidiary to enhance its presence in the region.
Broughton's Chief Scientific and Regulatory Officer, Dr Nveed Chaudhary discusses what developments are expected over the next 12 months ...
Broughton's Head of Regulatory Affairs, Lloyd Smart, and Regulatory Consultant, Xiangyin Wei summarise China's Tobacco Monopoly Law Changes ...
Broughton, a global Contract Research Organization rapidly developing its position as a full-service solutions provider to the global life ...
Broughton's Director of Product Development Services, Dr Fozia Saleem, and Technical Sales Administrator, Curtis Gallagher collaborates ...
Broughton's Head of Regulatory Affairs, Lloyd Smart has recently published an article with the leading sector publication Tobacco Reporter.
Broughton's Chief Scientific Officer, Chris Allen shares his opinion with Financial Times about e-cigarettes on the NHS.
Aligned with Broughton’s belief in realizing harm reduction, Principal Scientist, Frazer Lowe discusses a scientific paper that he ...
Broughton's Chief Scientific Officer, Chris Allen, and Technical Sales Administrator, Curtis Gallagher join with leading global ...
Broughton's Head of Regulatory Affairs, Lloyd Smart discusses the latest UK Medicines & Healthcare products Regulatory Agency (MHRA) ...
Broughton's Head of Regulatory Affairs, Lloyd Smart discusses Food and Drug Administration (FDA) final ruling for Premarket Tobacco Product ...
Broughton's Head of Regulatory Affairs, Lloyd Smart discusses the Australian Government's recent announcement regarding existing nicotine ...
Broughton's Chief Regulatory Officer, Dr Nveed Chaudhary shares his post-event reflections on Global Tobacco Nicotine Forum (GTNF) 2021.
Broughton Head of Scientific Affairs, Paul Hardman has recently published an article with leading sector publication Tobacco Reporter.
Broughton employees take on 600-mile challenge and dragon boat race to raise funds for a mental health charity
Broughton Chief Scientific Officer, Chris Allen shares his thoughts ahead of this year's Global Tobacco & Nicotine Forum (GTNF) taking ...
Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary shares his thoughts on yesterday's announcement from the Food and Drug ...
Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary shares his thoughts on the latest Food and Drug Administration (FDA) updates ...
Broughton asked industry expert, Dr Ian Fearon, to explain the process followed when running clinical trials.
Broughton Head of Scientific Affairs, Paul Hardman has today published an article with leading sector publication Tobacco Reporter that ...
Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary, discusses the global challenges the ENDS industry faces to achieve a smoke-free ...
Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary, summarises the latest US Food and Drug Administration (FDA) Centre for Tobacco ...
Broughton Head of Scientific Affairs, Paul Hardman outlines factors that can lead to data gaps in Premarket Tobacco Product Applications ...
Broughton Director of Product Safety and Compliance, Yvonne Wilding, discusses implications of Brexit on the international ENDS market.
Broughton is delighted to announce that Paul Hardman joins as Head of Scientific Affairs. This latest appointment further bolsters the ...
Broughton Chief Regulatory Officer, Dr Nveed Chaudhary shares his thoughts on the latest FDA announcement, ‘Clarification on General ...
Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary to present the future challenges of the ENDS regulatory battleground and the ...
Broughton Chief Regulatory Officer, Dr Nveed Chaudhary announces the launch of our Blue-sky thinking hub aimed at nicotine, pharmaceutical, ...
Broughton Dr Nveed Chaudhary, Chief Regulatory Officer discusses the EU's stance on Next Generation Products and what this means for ...
Broughton Dr Nveed Chaudhary, Chief Regulatory Officer, discusses Deficiency Letters and data gap fulfillment and why the time to act is ...
Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary discusses business growth and Broughton’s plans to extend its service portfolio ...
Broughton Regulatory Operations Manager, Emily Saunders, discusses FDAs announcement on the final ruling for PMTA applications.
Over last 40 years Pharmaceuticals has aligned around The International Council for Harmonisation of Technical Requirements for ...
Broughton Director of Product Safety and Compliance, Yvonne Wilding, discusses a leading-edge software tool designed and in use at ...
Broughton Chief Scientific Officer, Chris Allen, discusses the sensitivity of analytical methods appropriate for Toxicological assessment ...
Broughton, Director of Product Safety and Compliance, Yvonne Wilding and Principal Scientist, Louise Neilson will be in attendance and ...
Broughton Director of Product Safety and Compliance, Yvonne Wilding, looks at the recent Tobacco Product Perception and Intention studies ...
Broughton , Director of Product Safety and Compliance, Yvonne Wilding has recently published an article with leading sector publication ...
Emily Saunders, Regulatory Operations Manager, takes a look at the potential delay to the Tobacco Product Directive (TPD3) and the future ...
Broughton announce, Chief Scientific Officer to join panel discussion at GTNF 2020
Broughton, Senior Project Scientist, will participate in a webinar hosted by Separation Science, sponsored by Thermo Fisher Scientific.
As the September 9th, 2020 PMTA deadline rapidly approaches, our Chief Scientific Officer, Chris Allen, takes a look at the current US ...
Broughton, Chief Scientific Officer has recently published an article with leading sector publication Tobacco Reporter – Counting Down to ...
Broughton are pleased to take part in Thermo Fisher Scientific’s video series - Charlie Chats.
Broughton, Chief Scientific Officer has recently published an article with leading sector publication Tobacco Reporter – Measuring up
Broughton announce new webinar.
In silico methods for the prediction of toxicity are becoming more widely used in the field of toxicology.
Broughton has produced an infographic to explain the process for toxicology risk assessments for Electronic Nicotine Delivery Systems ...
Broughton, Marketing Manager discusses changing times, virtual events and embracing technology.
This article provides an overview of the different types of toxicological studies typically undertaken, and how they support regulatory ...
Broughton announce expansion of Toxicology team directed by Yvonne Wilding.
Extension of the Premarket Tobacco Product Application (PMTA) deadline, requested by the US Food and Drug Administration (FDA) due to the ...
A recent announcement from The Food and Drug Administration (FDA) on the Premarket Tobacco Authorization (PMTA) final ruling means that the ...
The US Food and Drug Administration (FDA) has requested an extension to the Premarket Tobacco Product Application (PMTA) deadline due to ...
We’re delighted to announce that Broughton has launched an in-house toxicology services division to increase our capacity and introduce ...
Society for Research on Nicotine & Tobacco (SRNT) is a four-day event that provides attendees with an opportunity to exchange knowledge ...
Alan Hutchinson, Principal Scientist at Broughton, has recently published an article with Laboratory News; the leading magazine for UK ...
Are you confused by the ENDS flavor debate? Dr. Ian Fearon, Broughton subject matter expert for clinical studies, has recently published an ...
The US Food and Drug Administration (FDA) has published final guidance regarding Enforcement Priorities for Electronic Nicotine Delivery ...
We’re delighted to announce that Broughton has recently launched an in-house service focused on enabling companies in the Electronic ...
ENDS US 2019 is the ideal place to keep up with the ever-changing knowledge base required to operate in the nicotine products industry; the ...
We are delighted to announce that Broughton has made a series of major business transactions to meet the demands of our growing portfolio.
One of Europe's leading nicotine product conferences is in London on 5th and 6th November. Head over to the Amba Hotel, Marble Arch to ...
The US Food and Drug Administration (FDA) recently published a “Proposed Rule” for the Electronic Nicotine Delivery Systems (ENDS) sector. ...
As we mentioned in our previous article, Final PMTA guidance has arrived – what’s changed?, FDA has modified the list of constituents or ...
Recently the Broughton team took part in a fun afternoon together in Wycoller Country Park, Lancashire. A test of knowledge, creativity and ...
The latest statement from FDA Commissioner, Scott Gottlieb, outlines the agency’s actions to ensure sound regulation of tobacco products, ...
Tobacco product manufacturers are required to comply with certain requirements under Section 904(a) of the Federal Food, Drug and Cosmetic ...
We are delighted to officially announce the recent launch of Broughton Limited, a spin-off from the long-established Broughton. The new ...
It appears so, following a series of significant recent FDA announcements regarding Harmful and Potentially Harmful Constituent (HPHC) ...
FDA regulated industries, including the ENDS industry, have few opportunities to engage with the FDA and receive valuable, bespoke product ...
Hot on the heels of the Next Generation Nicotine event in London, the ENDS US conference took place on the 5th through the 7th of December ...
Time passes by but the regulatory uncertainty in the US market shows no sign of ending.
‘This runaway train has no brakes.’
Save the date. Monday 22nd October is looking like a key day for the US ENDS industry.
Electronic cigarettes are battery powered electronic devices that enable delivery of nicotine to a user without the combustion processes of ...
Last week we attended the Vape and the FDA event hosted by the Vapor Technology Association (VTA) in Washington DC. It was great to catch ...
Maintaining regulatory compliance is a key factor in keeping your Electronic Nicotine Delivery System (ENDS) products on the market. A ...
Photo by: R&D Magazine Leslie Henderson, our Operations Directory at Broughton, became a co-guest writer on R&D Magazine with ...
Chris Allen, Managing Director of Broughton, is pleased to present at Keller and Heckman's 2nd Annual E-Vapor and Tobacco Law Symposium in ...
The FDA has issued its latest guidance to the tobacco product industry, including Electronic Nicotine Delivery Systems (ENDS). The guidance ...
One of Europe's leading nicotine product conference is in London this week.
On Friday, July 28th, the FDA issued a press release announcing the new plan for tobacco and nicotine regulation. There has been much ...
With confusion and uncertainty on all sides surrounding the FDA regulations, the ENDS industry came together once again for the Vape and ...
The key strapline echoed by many key figures within the industry was ‘the FDA regulations are here to stay, and we just have to deal with ...
Broughton , an MHRA and FDA inspected GMP analytical services laboratory that has been testing Nicotine products since 2010, will be ...
A fascinating debate and discussion were order of the day once again at the latest E-Cig Summit. After the success of the UK events this ...
FDA Announced on 3rd May, 2017 that all outstanding compliance deadlines for PMTA have been extended by 3 Months
On May 10th, 2016, FDA issued a final rule extending its tobacco product authority to all tobacco products (except for accessories of ...
On the 20thMay 2016 the Tobacco and Related Products Regulations implemented the TPD (Tobacco Products Directive). This regulation set out ...
It was the same conference last year where many in the vaping industry realised that changes were coming with regards to the regulations. ...
With only a couple of weeks left until the 19th of November we have helped many clients ensure their products are TPD compliant and we ...
We have just announced via email to our followers regarding further clarification from the MHRA. Subsequent guidance has been provided by ...
Since the issue of the EU Tobacco Products Directive of 2014, many counter arguments have been put forward against certain aspects of the ...
The Next Generation Nicotine Delivery 2015 Conference in London a few weeks ago was an invaluable event for the industry. A lot of the ...